{"id":"6edcafc2-2d83-426f-b2bb-a8ab5b1f0de3","kind":"companies","code":"UB-C7819","name":"Side Medical","nameBasis":"transliterated","summary":"Side Medical is a company headquartered in Guangzhou, China.","description":"","country":"China","category":null,"originalName":"思德医疗","eventDate":null,"website":"http://sidece.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-15T17:35:38.307Z","reviewedAt":"2026-10-15T17:35:38.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ab3b87869f30a2d9457bf4c9cef31b92415cae2dab168751a6d2ba556b04abe6","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"d027e4a1-dd7b-4c40-bf79-9176feb90009","kind":"news","code":"d027e4a1-dd7b-4c40-bf79-9176feb90009","name":"Side Medical completes equity financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"思德医疗完成股权投资融资","eventDate":"2025-11-11T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T17:03:36.441Z","englishUpdatedAt":"2026-10-15T17:35:40.697Z","reviewedAt":"2026-10-15T17:35:40.697Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e02ce710fdb167c61571be2c422e70fbeb68f79771e009604469f84b672f5b63","companyId":"6edcafc2-2d83-426f-b2bb-a8ab5b1f0de3","foundedYear":null,"logoUrl":null,"path":"/news/d027e4a1-dd7b-4c40-bf79-9176feb90009"},{"id":"0d5c84ff-32dc-43cf-997b-fa6fd69491cf","kind":"news","code":"0d5c84ff-32dc-43cf-997b-fa6fd69491cf","name":"Side Medical completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"思德医疗完成战略投资融资","eventDate":"2024-07-01T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:40:25.728Z","englishUpdatedAt":"2026-10-15T17:35:40.486Z","reviewedAt":"2026-10-15T17:35:40.486Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1723de424ef9c6110e3b3cef973fcf4f4b129e08c3b126551b0a6ab5a500d0b6","companyId":"6edcafc2-2d83-426f-b2bb-a8ab5b1f0de3","foundedYear":null,"logoUrl":null,"path":"/news/0d5c84ff-32dc-43cf-997b-fa6fd69491cf"},{"id":"66c2f3b8-4ed9-47a7-b705-76a09d27bca1","kind":"news","code":"66c2f3b8-4ed9-47a7-b705-76a09d27bca1","name":"Side Medical completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"思德医疗完成战略投资融资","eventDate":"2025-06-27T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:40:27.927Z","englishUpdatedAt":"2026-10-15T17:35:40.588Z","reviewedAt":"2026-10-15T17:35:40.588Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"de10f7bda835aae6ba9cddd9ce4e10fc34cd76c6bc2a647c4f67eee388fe197c","companyId":"6edcafc2-2d83-426f-b2bb-a8ab5b1f0de3","foundedYear":null,"logoUrl":null,"path":"/news/66c2f3b8-4ed9-47a7-b705-76a09d27bca1"},{"id":"fde7c081-b02a-4bb0-861b-c2ac1ff6596b","kind":"institutions","code":"UB-I1615","name":"万联天泽","nameBasis":"transliterated","summary":"Investment management platform under Wanlian Securities.","description":"Investment management platform under Wanlian Securities.","country":null,"category":null,"originalName":"万联天泽","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.232Z","englishUpdatedAt":"2026-10-15T20:18:30.771Z","reviewedAt":"2026-10-15T20:18:30.771Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0d86d921e1ab5741adfa448e20e599c74e5cfc2c368df7eb891384431a61564f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanliantianze","path":"/institutions/wanliantianze"},{"id":"43634ae2-b9cc-4edc-8bd4-5a256af7e507","kind":"institutions","code":"UB-I2156","name":"万联广生","nameBasis":"transliterated","summary":"Equity investment platform affiliated with Wanlian Securities.","description":"Equity investment platform affiliated with Wanlian Securities.","country":null,"category":null,"originalName":"万联广生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:24.547Z","englishUpdatedAt":"2026-10-15T19:58:05.028Z","reviewedAt":"2026-10-15T19:58:05.028Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e4968238fbce67deec7e816071814102fe6c8fd36ac210665895333bc1540cbd","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanlianguangsheng","path":"/institutions/wanlianguangsheng"},{"id":"2e6e3edf-a4ca-4902-ba52-aa0c6f05e73f","kind":"institutions","code":"UB-I6520","name":"广州金控基金","nameBasis":"transliterated","summary":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","description":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","country":null,"category":null,"originalName":"广州金控基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:22.631Z","englishUpdatedAt":"2026-10-15T18:26:24.774Z","reviewedAt":"2026-10-15T18:26:24.774Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5073f4d790e40fa3d28360c663f9261045511778f20e83df2e6dd454276ab9b7","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangzhou Jinkong Fund","path":"/institutions/guangzhou-jinkong-fund"},{"id":"7e112bb0-b027-4268-a32e-24106887453f","kind":"institutions","code":"UB-I1531","name":"广药集团","nameBasis":"transliterated","summary":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","description":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","country":null,"category":null,"originalName":"广药集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.838Z","englishUpdatedAt":"2026-10-15T21:41:18.601Z","reviewedAt":"2026-10-15T21:41:18.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"09cd2ec733297f69225b782fc2758eda1257cd1d9770fcb86c73e720f2a13bcf","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangyao Group","path":"/institutions/guangyao-group"},{"id":"0ddceb34-52ba-422d-959e-ab04d4f7ebee","kind":"institutions","code":"UB-I1568","name":"鲸犀投资","nameBasis":"transliterated","summary":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","description":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","country":null,"category":null,"originalName":"鲸犀投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:26.702Z","englishUpdatedAt":"2026-10-15T18:43:03.500Z","reviewedAt":"2026-10-15T18:43:03.500Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ea697829dea4229cc42a347538c1e265aed7b7b38ab372b83af97b83bfe14ffc","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingxi Investment","path":"/institutions/jingxi-investment"}],"finance":{"funding":{"metric":"funding","count":3,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":3,"records":[{"id":"d027e4a1-dd7b-4c40-bf79-9176feb90009","date":"2025-11-11T00:00:00.000Z","round":"Equity","amountText":"未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"广药集团,鲸犀投资","institutions":[{"id":"7e112bb0-b027-4268-a32e-24106887453f","kind":"institutions","code":"UB-I1531","name":"广药集团","nameBasis":"transliterated","summary":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","description":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","country":null,"category":null,"originalName":"广药集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.838Z","englishUpdatedAt":"2026-10-15T21:41:18.601Z","reviewedAt":"2026-10-15T21:41:18.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"09cd2ec733297f69225b782fc2758eda1257cd1d9770fcb86c73e720f2a13bcf","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangyao Group","path":"/institutions/guangyao-group"},{"id":"0ddceb34-52ba-422d-959e-ab04d4f7ebee","kind":"institutions","code":"UB-I1568","name":"鲸犀投资","nameBasis":"transliterated","summary":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","description":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","country":null,"category":null,"originalName":"鲸犀投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:26.702Z","englishUpdatedAt":"2026-10-15T18:43:03.500Z","reviewedAt":"2026-10-15T18:43:03.500Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ea697829dea4229cc42a347538c1e265aed7b7b38ab372b83af97b83bfe14ffc","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingxi Investment","path":"/institutions/jingxi-investment"}],"newsUrl":null,"evidence":{"headline":"Side Medical completes equity financing","brief":null,"basis":null,"newsPath":"/news/d027e4a1-dd7b-4c40-bf79-9176feb90009","sourceCount":0}},{"id":"66c2f3b8-4ed9-47a7-b705-76a09d27bca1","date":"2025-06-27T00:00:00.000Z","round":"Strategic","amountText":"未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"广州金控基金","institutions":[{"id":"2e6e3edf-a4ca-4902-ba52-aa0c6f05e73f","kind":"institutions","code":"UB-I6520","name":"广州金控基金","nameBasis":"transliterated","summary":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","description":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","country":null,"category":null,"originalName":"广州金控基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:22.631Z","englishUpdatedAt":"2026-10-15T18:26:24.774Z","reviewedAt":"2026-10-15T18:26:24.774Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5073f4d790e40fa3d28360c663f9261045511778f20e83df2e6dd454276ab9b7","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangzhou Jinkong Fund","path":"/institutions/guangzhou-jinkong-fund"}],"newsUrl":null,"evidence":{"headline":"Side Medical completes strategic financing","brief":null,"basis":null,"newsPath":"/news/66c2f3b8-4ed9-47a7-b705-76a09d27bca1","sourceCount":0}},{"id":"0d5c84ff-32dc-43cf-997b-fa6fd69491cf","date":"2024-07-01T00:00:00.000Z","round":"Strategic","amountText":"未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"万联广生,万联天泽","institutions":[{"id":"fde7c081-b02a-4bb0-861b-c2ac1ff6596b","kind":"institutions","code":"UB-I1615","name":"万联天泽","nameBasis":"transliterated","summary":"Investment management platform under Wanlian Securities.","description":"Investment management platform under Wanlian Securities.","country":null,"category":null,"originalName":"万联天泽","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.232Z","englishUpdatedAt":"2026-10-15T20:18:30.771Z","reviewedAt":"2026-10-15T20:18:30.771Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0d86d921e1ab5741adfa448e20e599c74e5cfc2c368df7eb891384431a61564f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanliantianze","path":"/institutions/wanliantianze"},{"id":"43634ae2-b9cc-4edc-8bd4-5a256af7e507","kind":"institutions","code":"UB-I2156","name":"万联广生","nameBasis":"transliterated","summary":"Equity investment platform affiliated with Wanlian Securities.","description":"Equity investment platform affiliated with Wanlian Securities.","country":null,"category":null,"originalName":"万联广生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:24.547Z","englishUpdatedAt":"2026-10-15T19:58:05.028Z","reviewedAt":"2026-10-15T19:58:05.028Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e4968238fbce67deec7e816071814102fe6c8fd36ac210665895333bc1540cbd","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanlianguangsheng","path":"/institutions/wanlianguangsheng"}],"newsUrl":null,"evidence":{"headline":"Side Medical completes strategic financing","brief":null,"basis":null,"newsPath":"/news/0d5c84ff-32dc-43cf-997b-fa6fd69491cf","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":3,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":3,"records":[{"id":"d027e4a1-dd7b-4c40-bf79-9176feb90009","date":"2025-11-11T00:00:00.000Z","round":"Equity","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"广药集团,鲸犀投资","institutions":[{"id":"7e112bb0-b027-4268-a32e-24106887453f","kind":"institutions","code":"UB-I1531","name":"广药集团","nameBasis":"transliterated","summary":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","description":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","country":null,"category":null,"originalName":"广药集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.838Z","englishUpdatedAt":"2026-10-15T21:41:18.601Z","reviewedAt":"2026-10-15T21:41:18.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"09cd2ec733297f69225b782fc2758eda1257cd1d9770fcb86c73e720f2a13bcf","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangyao Group","path":"/institutions/guangyao-group"},{"id":"0ddceb34-52ba-422d-959e-ab04d4f7ebee","kind":"institutions","code":"UB-I1568","name":"鲸犀投资","nameBasis":"transliterated","summary":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","description":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","country":null,"category":null,"originalName":"鲸犀投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:26.702Z","englishUpdatedAt":"2026-10-15T18:43:03.500Z","reviewedAt":"2026-10-15T18:43:03.500Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ea697829dea4229cc42a347538c1e265aed7b7b38ab372b83af97b83bfe14ffc","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingxi Investment","path":"/institutions/jingxi-investment"}],"newsUrl":null,"evidence":{"headline":"Side Medical completes equity financing","brief":null,"basis":null,"newsPath":"/news/d027e4a1-dd7b-4c40-bf79-9176feb90009","sourceCount":0}},{"id":"66c2f3b8-4ed9-47a7-b705-76a09d27bca1","date":"2025-06-27T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"广州金控基金","institutions":[{"id":"2e6e3edf-a4ca-4902-ba52-aa0c6f05e73f","kind":"institutions","code":"UB-I6520","name":"广州金控基金","nameBasis":"transliterated","summary":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","description":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","country":null,"category":null,"originalName":"广州金控基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:22.631Z","englishUpdatedAt":"2026-10-15T18:26:24.774Z","reviewedAt":"2026-10-15T18:26:24.774Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5073f4d790e40fa3d28360c663f9261045511778f20e83df2e6dd454276ab9b7","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangzhou Jinkong Fund","path":"/institutions/guangzhou-jinkong-fund"}],"newsUrl":null,"evidence":{"headline":"Side Medical completes strategic financing","brief":null,"basis":null,"newsPath":"/news/66c2f3b8-4ed9-47a7-b705-76a09d27bca1","sourceCount":0}},{"id":"0d5c84ff-32dc-43cf-997b-fa6fd69491cf","date":"2024-07-01T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"万联广生,万联天泽","institutions":[{"id":"fde7c081-b02a-4bb0-861b-c2ac1ff6596b","kind":"institutions","code":"UB-I1615","name":"万联天泽","nameBasis":"transliterated","summary":"Investment management platform under Wanlian Securities.","description":"Investment management platform under Wanlian Securities.","country":null,"category":null,"originalName":"万联天泽","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.232Z","englishUpdatedAt":"2026-10-15T20:18:30.771Z","reviewedAt":"2026-10-15T20:18:30.771Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0d86d921e1ab5741adfa448e20e599c74e5cfc2c368df7eb891384431a61564f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanliantianze","path":"/institutions/wanliantianze"},{"id":"43634ae2-b9cc-4edc-8bd4-5a256af7e507","kind":"institutions","code":"UB-I2156","name":"万联广生","nameBasis":"transliterated","summary":"Equity investment platform affiliated with Wanlian Securities.","description":"Equity investment platform affiliated with Wanlian Securities.","country":null,"category":null,"originalName":"万联广生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:24.547Z","englishUpdatedAt":"2026-10-15T19:58:05.028Z","reviewedAt":"2026-10-15T19:58:05.028Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e4968238fbce67deec7e816071814102fe6c8fd36ac210665895333bc1540cbd","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanlianguangsheng","path":"/institutions/wanlianguangsheng"}],"newsUrl":null,"evidence":{"headline":"Side Medical completes strategic financing","brief":null,"basis":null,"newsPath":"/news/0d5c84ff-32dc-43cf-997b-fa6fd69491cf","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"d027e4a1-dd7b-4c40-bf79-9176feb90009","kind":"funding","eventDate":"2025-11-11T00:00:00.000Z","revenueDate":null,"round":"股权投资","amountText":"未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"广药集团,鲸犀投资","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"7e112bb0-b027-4268-a32e-24106887453f","kind":"institutions","code":"UB-I1531","name":"广药集团","nameBasis":"transliterated","summary":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","description":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","country":null,"category":null,"originalName":"广药集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.838Z","englishUpdatedAt":"2026-10-15T21:41:18.601Z","reviewedAt":"2026-10-15T21:41:18.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"09cd2ec733297f69225b782fc2758eda1257cd1d9770fcb86c73e720f2a13bcf","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangyao Group","path":"/institutions/guangyao-group"},{"id":"0ddceb34-52ba-422d-959e-ab04d4f7ebee","kind":"institutions","code":"UB-I1568","name":"鲸犀投资","nameBasis":"transliterated","summary":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","description":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","country":null,"category":null,"originalName":"鲸犀投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:26.702Z","englishUpdatedAt":"2026-10-15T18:43:03.500Z","reviewedAt":"2026-10-15T18:43:03.500Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ea697829dea4229cc42a347538c1e265aed7b7b38ab372b83af97b83bfe14ffc","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingxi Investment","path":"/institutions/jingxi-investment"}],"roundName":"Equity","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"66c2f3b8-4ed9-47a7-b705-76a09d27bca1","kind":"funding","eventDate":"2025-06-27T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"广州金控基金","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"2e6e3edf-a4ca-4902-ba52-aa0c6f05e73f","kind":"institutions","code":"UB-I6520","name":"广州金控基金","nameBasis":"transliterated","summary":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","description":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","country":null,"category":null,"originalName":"广州金控基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:22.631Z","englishUpdatedAt":"2026-10-15T18:26:24.774Z","reviewedAt":"2026-10-15T18:26:24.774Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5073f4d790e40fa3d28360c663f9261045511778f20e83df2e6dd454276ab9b7","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangzhou Jinkong Fund","path":"/institutions/guangzhou-jinkong-fund"}],"roundName":"Strategic","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"0d5c84ff-32dc-43cf-997b-fa6fd69491cf","kind":"funding","eventDate":"2024-07-01T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"万联广生,万联天泽","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"fde7c081-b02a-4bb0-861b-c2ac1ff6596b","kind":"institutions","code":"UB-I1615","name":"万联天泽","nameBasis":"transliterated","summary":"Investment management platform under Wanlian Securities.","description":"Investment management platform under Wanlian Securities.","country":null,"category":null,"originalName":"万联天泽","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.232Z","englishUpdatedAt":"2026-10-15T20:18:30.771Z","reviewedAt":"2026-10-15T20:18:30.771Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0d86d921e1ab5741adfa448e20e599c74e5cfc2c368df7eb891384431a61564f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanliantianze","path":"/institutions/wanliantianze"},{"id":"43634ae2-b9cc-4edc-8bd4-5a256af7e507","kind":"institutions","code":"UB-I2156","name":"万联广生","nameBasis":"transliterated","summary":"Equity investment platform affiliated with Wanlian Securities.","description":"Equity investment platform affiliated with Wanlian Securities.","country":null,"category":null,"originalName":"万联广生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:24.547Z","englishUpdatedAt":"2026-10-15T19:58:05.028Z","reviewedAt":"2026-10-15T19:58:05.028Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e4968238fbce67deec7e816071814102fe6c8fd36ac210665895333bc1540cbd","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanlianguangsheng","path":"/institutions/wanlianguangsheng"}],"roundName":"Strategic","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"fde7c081-b02a-4bb0-861b-c2ac1ff6596b","kind":"institutions","code":"UB-I1615","name":"万联天泽","nameBasis":"transliterated","summary":"Investment management platform under Wanlian Securities.","description":"Investment management platform under Wanlian Securities.","country":null,"category":null,"originalName":"万联天泽","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.232Z","englishUpdatedAt":"2026-10-15T20:18:30.771Z","reviewedAt":"2026-10-15T20:18:30.771Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0d86d921e1ab5741adfa448e20e599c74e5cfc2c368df7eb891384431a61564f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanliantianze","path":"/institutions/wanliantianze"},{"id":"43634ae2-b9cc-4edc-8bd4-5a256af7e507","kind":"institutions","code":"UB-I2156","name":"万联广生","nameBasis":"transliterated","summary":"Equity investment platform affiliated with Wanlian Securities.","description":"Equity investment platform affiliated with Wanlian Securities.","country":null,"category":null,"originalName":"万联广生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:24.547Z","englishUpdatedAt":"2026-10-15T19:58:05.028Z","reviewedAt":"2026-10-15T19:58:05.028Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e4968238fbce67deec7e816071814102fe6c8fd36ac210665895333bc1540cbd","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Wanlianguangsheng","path":"/institutions/wanlianguangsheng"},{"id":"2e6e3edf-a4ca-4902-ba52-aa0c6f05e73f","kind":"institutions","code":"UB-I6520","name":"广州金控基金","nameBasis":"transliterated","summary":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","description":"Guangzhou Jinkong Fund is a Chinese government-backed guidance fund, supporting the development of technology companies through equity investment.","country":null,"category":null,"originalName":"广州金控基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:22.631Z","englishUpdatedAt":"2026-10-15T18:26:24.774Z","reviewedAt":"2026-10-15T18:26:24.774Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5073f4d790e40fa3d28360c663f9261045511778f20e83df2e6dd454276ab9b7","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangzhou Jinkong Fund","path":"/institutions/guangzhou-jinkong-fund"},{"id":"7e112bb0-b027-4268-a32e-24106887453f","kind":"institutions","code":"UB-I1531","name":"广药集团","nameBasis":"transliterated","summary":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","description":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","country":null,"category":null,"originalName":"广药集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.838Z","englishUpdatedAt":"2026-10-15T21:41:18.601Z","reviewedAt":"2026-10-15T21:41:18.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"09cd2ec733297f69225b782fc2758eda1257cd1d9770fcb86c73e720f2a13bcf","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guangyao Group","path":"/institutions/guangyao-group"},{"id":"0ddceb34-52ba-422d-959e-ab04d4f7ebee","kind":"institutions","code":"UB-I1568","name":"鲸犀投资","nameBasis":"transliterated","summary":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","description":"Jingxi Investment is a mainland Chinese venture capital firm, focused on startup investment.","country":null,"category":null,"originalName":"鲸犀投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:26.702Z","englishUpdatedAt":"2026-10-15T18:43:03.500Z","reviewedAt":"2026-10-15T18:43:03.500Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ea697829dea4229cc42a347538c1e265aed7b7b38ab372b83af97b83bfe14ffc","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jingxi Investment","path":"/institutions/jingxi-investment"}],"path":"/companies/UB-C7819","structured":{"city":"Guangzhou","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Side Medical is a company headquartered in Guangzhou, China.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C7819"}